Leishmania donovani BPK282A1 complete genome, chromosome 15.
Eukaryota; Euglenozoa; Kinetoplastida; Trypanosomatidae; Leishmaniinae; Leishmania.
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance
Submitted (30-MAR-2018) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA
Submitted (25-JAN-2011) Aslett M., Pathogen Sequencing Unit, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, Cambridgeshire CB10 1SA, UNITED KINGDOM
PROVISIONAL REFSEQ: This record has not yet been subject to final\nNCBI review. The reference sequence is identical to FR799602.\nData release policy http://www.sanger.ac.uk/legal/#t_2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: INSDC submitter\nAnnotation Status :: Full annotation\nAnnotation Pipeline :: Eukaryotic Annotation Propagation Pipeline\n##Genome-Annotation-Data-END##
heat shock protein HslVU, ATPase subunit HslU, putative
serine/threonine-protein kinase, putative
protein phosphatase 1 catalitic subunit, putative
nonspecific lipid-transfer protein, putative
replication Factor A 28 kDa subunit, putative
ribonucleoprotein p18, mitochondrial precursor, putative
cytoplasmic l-asparaginase i-like protein
ATP-binding cassette protein subfamily A, member 7, putative
ATP-binding cassette protein subfamily G, member 4, putative
protein phosphatase 2A regulatory subunit, putative
NAD/FAD dependent dehydrogenase, putative
solanesyl-diphosphate synthase, putative
developmentally regulated protein, putative
inositol/phosphatidylinositol phosphatase, putative
Short protein (LDBPK_151300, CBZ32944.1) was converted to a misc_feature.
proliferative cell nuclear antigen (PCNA), putative
cAMP specific phosphodiesterase, putative
presenilin-like aspartic peptidase, putative